Questions arise over GE bid

Article

GE may not get all it wants from its bid to acquire Instrumentarium. The London-based Financial Times reports that GE may have to sell off some assets to obtain permission from the European Union for the takeover. Brussels is pushing hard for concessions

GE may not get all it wants from its bid to acquire Instrumentarium. The London-based Financial Times reports that GE may have to sell off some assets to obtain permission from the European Union for the takeover. Brussels is pushing hard for concessions as part of a probe into the effects of the proposed merger. The probe was launched by the EU in early April (SCAN 4/16/03). Regulators' concerns have been heightened by objections to the deal from GE rivals Siemens and Philips, according to the Times.

The sale of at least some of Instrumentarium's patient monitoring business might be the price GE will have to pay for the deal to go through, the Times reported. Other assets involving mobile x-ray and mammography equipment may also have to go. These demands could appear in a "statement of objections" to be sent to Instrumentarium and GE in the next few weeks. Joseph Hogan, president and CEO of GE Medical, predicted three months ago that no disposals would be needed in order to gain European approval. The final outcome is a long way from being decided, however, as the EU probe into the proposed deal is only in the early stages. The EU investigation is expected to continue into August.

Recent Videos
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
Related Content
© 2025 MJH Life Sciences

All rights reserved.